Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.65 USD | -2.12% | -4.87% | +122.28% |
May. 15 | Cullinan Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 15 | Cullinan Therapeutics, Inc. Announces Board Changes | CI |
Business Summary
Number of employees: 85
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 21-10-17 |
Jeffrey Jones
CTO | Chief Tech/Sci/R&D Officer | 53 | 22-02-27 |
Jacquelyn Sumer
CMP | Compliance Officer | 46 | 22-08-14 |
Chief Tech/Sci/R&D Officer | 57 | 17-12-31 | |
Kevin Johnston
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-30 |
Chad Messer
IRC | Investor Relations Contact | - | 22-02-28 |
Corinne Savill
PRN | Corporate Officer/Principal | 64 | 17-01-31 |
Stephen Andre
HRO | Human Resources Officer | 62 | 22-03-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 71 | 17-07-31 | |
Thomas Ebeling
BRD | Director/Board Member | 65 | 17-07-31 |
Stephen Webster
BRD | Director/Board Member | 63 | 20-08-31 |
Nadim Ahmed
CEO | Chief Executive Officer | 56 | 21-10-17 |
Director/Board Member | 52 | 22-02-27 | |
David Ryan
BRD | Director/Board Member | 57 | 22-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 57,634,234 | 54,879,379 ( 95.22 %) | 0 | 95.22 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+122.28% | 1.31B | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+44.64% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- CGEM Stock
- Company Cullinan Therapeutics, Inc.